| Literature DB >> 23050227 |
Priti Azad1, Dan Zhou, Rachel Zarndt, Gabriel G Haddad.
Abstract
Hypoxia occurs in physiologic conditions (e.g. high altitude) or during pathologic states (e.g. ischemia). Our research is focused on understanding the molecular mechanisms that lead to adaptation and survival or injury to hypoxic stress using Drosophila as a model system. To identify genes involved in hypoxia tolerance, we screened the P-SUP P-element insertion lines available for all the chromosomes of Drosophila. We screened for the eclosion rates of embryos developing under 5% O(2) condition and the number of adult flies surviving one week after eclosion in the same hypoxic environment. Out of 2187 lines (covering ~1870 genes) screened, 44 P-element lines representing 44 individual genes had significantly higher eclosion rates (i.e. >70%) than those of the controls (i.e. ~7-8%) under hypoxia. The molecular function of these candidate genes ranged from cell cycle regulation, DNA or protein binding, GTP binding activity, and transcriptional regulators. In addition, based on pathway analysis, we found these genes are involved in multiple pathways, such as Notch, Wnt, Jnk, and Hedgehog. Particularly, we found that 20 out of the 44 candidate genes are linked to Notch signaling pathway, strongly suggesting that this pathway is essential for hypoxia tolerance in flies. By employing the UAS/RNAi-Gal4 system, we discovered that genes such as osa (linked to Wnt and Notch pathways) and lqf (Notch regulator) play an important role in survival and development under hypoxia in Drosophila. Based on these results and our previous studies, we conclude that hypoxia tolerance is a polygenic trait including the Notch pathway.Entities:
Keywords: Notch pathway; development and survival; hypoxia; lqf; osa
Mesh:
Substances:
Year: 2012 PMID: 23050227 PMCID: PMC3464109 DOI: 10.1534/g3.112.003681
Source DB: PubMed Journal: G3 (Bethesda) ISSN: 2160-1836 Impact factor: 3.154
Percentage eclosion and number of adult flies surviving in controls (CS, yw) and P-element lines at 5% O2
| Gene Symbol | Chr | % Eclosion | Adult Flies | % Pupriation | Molecular Function | Human Orthologs |
|---|---|---|---|---|---|---|
| Gene Name/Symbol | ||||||
| CS(control) | 6.8 ± 0.67 | 1 ± 0.03 | 85.7 ± 5.68 | |||
| yw(control) | 7.5 ± 2.15 | 0 | 81.5 ± 10.25 | |||
| CG14782 | X | 75 ± 10.5 | 10 ± 5.4 | 97 ± 6.7 | Guanyl-nucleotide exchange factor activity | Pleckstrin homology domain containing, family F (with FYVE domain) member 2/ PLEKHF2 |
| CG15742 | X | 75 ± 13.3 | 4 ± 0.9 | 89 ± 10.12 | Unknown | |
| CG9413 | X | 80 ± 8.9 | 10 ± 5.8 | 78 ± 5.15 | Amino acid trasmembrane transporter activity | Solute carrier family 7 (glycoprotein-associated amino acid transporter light chain, bo,+ system), member 9/ SLC7A9 |
| Dip1 | X | 72 ± 9.9 | 8 ± 2.3 | 75 ± 3.22 | Double-stranded RNA binding | |
| CG10700 | 2 | 84.5 ± 0.95 | 20 ± 2.5 | 78 ± 10.2 | Electron carrier activity; FAD binding | |
| CG2915 | 2 | 74 ± 12 | 21 ± 1.8 | 69 ± 5.67 | Metallocarboxypeptidase activity; zinc ion binding | |
| CG30169 | 2 | 76 ± 23 | 5 ± 1.2 | 72 ± 12.35 | Unknown | |
| CG4612 | 2 | 71 ± 0.45 | 22 ± 6.7 | 89 ± 10.42 | mRNA binding; poly(A) binding; nucleotide binding | |
| CG6230 | 2 | 88 ± 3.5 | 47 ± 10.6 | 82 ± 12.5 | ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism; ATP binding | ATPase type 13A1/ ATP13A1 |
| CG6860 | 2 | 90.47 ± 5.7 | 23 ± 2.5 | 80 ± 13.45 | Protein binding | Leucine-rich repeats and calponin homology (CH) domain containing 1/ LRCH1 |
| CG8677 | 2 | 82.1 ± 7.4 | 3 ± 0.5 | 73.1 ± 9.4 | Transcription repressor activity; protein binding; zinc ion binding | Cat eye syndrome chromosome region, candidate 2/ CECR2 |
| cpa | 2 | 90 ± 3.6 | 42 ± 9 | 85 ± 11.5 | Actin binding | Capping protein (actin filament) muscle Z-line, alpha 1/ CAPZA1 |
| CycE | 2 | 70.4 ± 4.8 | 14 ± 6.8 | 72 ± 4.2 | Cyclin-dependent protein kinase regulator activity | |
| Drp1 | 2 | 72.5 ± 7.5 | 12 ± 4.8 | 73 ± 6.77 | GTP binding; GTPase activity | Dynamin 1-like/ DNM1L |
| Fak56D | 2 | 75.19 ± 0.57 | 5 ± 0.99 | 72.0 ± 10.22 | Protein tyrosine kinase activity | PTK2 protein tyrosine kinase 2/ PTK2 |
| mRpS18B | 2 | 88 ± 3.5 | 3 ± 1.3 | 76 ± 11.34 | Mitochondrial ribosomal protein, structural constituent of ribosome | Mitochondrial ribosomal protein S18B/MRPS18B |
| Mys45A | 2 | 89 ± 6 | 20 ± 7.9 | 81 ± 12.6 | Binding | SDA1 domain containing 1/ SDAD1 |
| Rep2 | 2 | 87.2 ± 2.25 | 39 ± 2.6 | 75.3 ± 10.27 | Protein binding | |
| Alh | 3 | 76 ± 4.5 | 5 ± 0.77 | 75 ± 8.77 | Transcription factor activity | Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila)/ MLLT10 |
| Atg1 | 3 | 88 ± 2.99 | 20 ± 3.6 | 93 ± 6.90 | Protein kinase activity; protein serine/threonine kinase activity; kinesin binding; kinase activity; ATP binding | Unc-51-like kinase 2 (C. elegans)/ ULK2 |
| Bgb | 3 | 87 ± 3.78 | 7 ± 1.3 | 77 ± 5.12 | Positive regulation of transcription from RNA polymerase II promoter | Core-binding factor, beta subunit/ CBFB |
| ced-6 | 3 | 73 ± 10.6 | 3 ± 0 | 83 ± 9.9 | Protein binding | GULP, engulfment adaptor PTB domain containing 1/ GULP1 |
| CG14185 | 3 | 83 ± 5.66 | 8 ± 3.44 | 69 ± 14.65 | Protein binding | |
| CG17273 | 3 | 86.7 ± 20.1 | 10 ± 2.3 | 82.7 ± 6.8 | Adenylosuccinate synthase activity; GTP binding | Adenylosuccinate synthase/ ADSS |
| CG32064 | 3 | 84.4 ± 4.5 | 30 ± 2.6 | 80 ± 9.23 | Proteolysis | |
| CG33169 | 3 | 76.5 ± 7.99 | 11 ± 2.7 | 96.5 ± 10.55 | Unknown | |
| CG5235 | 3 | 89 ± 9.7 | 16 ± 5.6 | 77 ± 12.6 | Dopamine beta-monooxygenase activity | Monooxygenase, DBH-like 1/ MOXD1 |
| CG6028 | 3 | 75 ± 10.89 | 20 ± 2.45 | 72 ± 9.8 | GTP binding | Fumarylacetoacetate hydrolase domain containing 2A/ FAHD2A |
| CG8116 | 3 | 89.2 ± 6.5 | 26 ± 12.7 | 92.2 ± 17.5 | Unknown | Transmembrane protein 216/ TMEM216 |
| CG8177 | 3 | 79 ± 8.97 | 10 ± 3.33 | 73 ± 3.2 | Anion exchanger activity; inorganic anion exchanger activity | Solute carrier family 4, anion exchanger, member 3/ SLC4A3 |
| CG8180 | 3 | 86 ± 1.33 | 7 ± 2.3 | 78 ± 7.8 | Unknown | |
| CG9737 | 3 | 77.6 ± 8.9 | 9 ± 2.2 | 80.6 ± 4.5 | Proteolysis; phagocytosis, engulfment | |
| chb | 3 | 70.8 ± 1.22 | 15 ± 1.2 | 90.2 ± 13.75 | GTP binding; microtubule binding | Cytoplasmic linker associated protein 1/ CLASP1 |
| Chro | 3 | 80 ± 7.9 | 7 ± 2 | 93 ± 6.49 | Chromatin binding | |
| l(3)mbn | 3 | 85 ± 6.79 | 32 ± 3.9 | 79 ± 8.5 | Plasmatocyte differentiation | |
| lqf | 3 | 90.3 ± 3.5 | 3 ± 0.22 | 93 ± 15.2 | Regulation of Notch signaling pathway | Epsin 3/ EPN3 |
| Manf | 3 | 86 ± 3.57 | 5 ± 2.22 | 92 ± 9.2 | Neuron maintenance; neuron projection development | Mesencephalic astrocyte-derived neurotrophic factor/ MANF |
| osa | 3 | 86.3 ± 9.9 | 58 ± 10.2 | 98.5 ± 10.3 | DNA binding; transcription coactivator activity | SWI/SNF |
| polo | 3 | 80 ± 2.35 | 11 ± 1 | 99 ± 10.34 | Cell cycle; protein kinase activity | Polo-like kinase 1/ PLK1 |
| pzg | 3 | 74 ± 1.5 | 11.5 ± 1.5 | 70 ± 3.67 | Cell cycle; establishment or maintenance of chromatin architecture; chromosome organization | |
| Scrib | 3 | 90 ± 2.1 | 18 ± 2 | 86 ± 10.7 | Protein binding | |
| sec8 | 3 | 85 ± 2 | 36 ± 6.9 | 77 ± 7.89 | Neurotransmitter secretion | |
| tna | 3 | 89 ± 9.86 | 20 ± 4.22 | 85 ± 12.5 | Chromatin-mediated maintenance of transcription | Zinc finger, MIZ-type containing 2/ ZMIZ2 |
| ci | 4 | 89 ± 6.77 | 5 ± 1.77 | 95 ± 8.95 | Protein binding, cell cycle regulation | GLI family zinc finger 3/ GLI3 |
Also shown are human orthologs of the candidate genes.
Figure 1P-element screen for hypoxia tolerance genes. Percentage eclosion and average number of adult flies surviving of P-element lines on chromosomes 1–4 at 5% O2. Each bar represents the average of at least three tests for each line (starting with 100–150 eggs); error bars represent the standard error. The number of lines tested for each chromosome is shown in brackets.
Figure 2Overrepresented functions in the hypoxia tolerant P-element lines as computed by GO. (A) Biological processes predominant for hypoxia tolerance (egg-adult) under 5% O2. (B) Molecular processes predominant for hypoxia tolerance (egg-adult) under 5% O2.
Signaling pathways linked to the candidate genes
| Symbol | Gene | Signaling Pathway |
|---|---|---|
| CG15742 | CG15742 | JNK modifier |
| Dip1 | CG15367 | 1) Innate immunity 2) Notch signaling |
| CG14782 | CG14782 | 1) JNK modifier 2) Notch signaling |
| CG9413 | CG9413 | Not detected |
| CG2915 | CG2915 | Not detected |
| mRpS18B | CG10757 | Notch signaling |
| Mys45A | CG8070 | 1) Lipid storage 2) Notch signaling 3) Cardiogenic genes |
| CG6230 | CG6230 | Notch signaling |
| cpa | CG10540 | 1) M. fortuitum infection 2) Morphogenesis 3) Phagocytosis |
| CG4612 | CG4612 | 1) JNK modifier 2) Mito Ca2+ and H+ regulation |
| CycE | CG3938 | 1) M. fortuitum infection 2) Morphogenesis 3) Lipid storage 4) miRNA pathway 5) cell cycle 6) p53 pathway 7) Ubiquitination pathway |
| Drp1 | CG3210 | 1) Mito morphology 2) Notch signaling 3) Ca2+ signaling (Ca2+ entry) 4) Endocytosis |
| Rep2 | CG1975 | Notch signaling |
| CG6860 | CG6860 | Not detected |
| Fak56D | CG10023 | 1) Angiogenesis 2) Integrin signaling pathway 3) VEGF signaling pathway |
| CG10700 | CG10700 | Not detected |
| CG30169 | CG30169 | Not detected |
| CG8677 | CG8677 | Not detected |
| osa | CG7467 | 1) Wnt signaling 2) Mito Ca2+ and H+ regulation 3) Notch signaling |
| CG32064 | CG32064 | 1) Glutathione metabolism 2) Sesquiterpenoid and triterpenoid biosynthesis in Urea cycle metabolism |
| CG8116 | CG8116 | Notch signaling |
| sec8 | CG2095 | 1) |
| Atg1 | CG10967 | 1) Cell cycle kinase 2) Notch pathway 3) Regulation of authophagy 4) mTOR signaling pathway |
| l(3)mbn | CG12755 | ERK signaling |
| CG5235 | CG5235 | Not detected |
| CG8177 | CG8177 | 1) Multipolar division 2) Ca2+ signaling (Ca2+ entry inhibition) |
| CG33169 | CG33169 | Notch signaling |
| CG17273 | CG17273 | 1) Innate immunity 2) Purine metabolism 3) Alanine-aspartate and glutamate metabolism 4) Wnt signaling pathway 5) De novo purine biosynthesis 6) Metabolic pathways |
| CG9737 | CG9737 | Phagocytosis |
| Chro | CG10712 | 1) M. fortuitum infection 2) Hedgehog signaling 3) Notch signaling |
| pzg | CG7752 | 1) JAK/STAT signaling 2) ERK signaling 3) E2F signaling 4) Notch signaling 5) Hedgehog signaling 6) M. fortuitum infection 7) Ca2+ signaling |
| ced6 | CG11804 | 1) |
| polo | CG12306 | 1) Cell cycle kinase 2) Kinase cell progression 3) Centrosome number 4) Mitosis 5) Morphogenesis 6) Cytoskeletal morphogenesis 7) DFoxO signaling 8) Notch signaling 9) Phagocytosis 10) Apoptosis pathway 11) Progesterone-mediated oocyte maturation 12) Endocytosis |
| Bgb | CG7959 | Not detected |
| Iqf | CG8532 | 1) Insect dengue virus infection 2) Endocytosis 3) Notch signaling |
| chb | CG32435 | 1) ERK signaling 2) Tublin flux 3) Mitosis |
| Scrib | CG42614 | 1) Innate immunity 2) Cardiogenic genes 3) Notch signaling 4) Ca2+ signaling |
| CG8180 | CG8180 | 1) JAK/STAT signaling 2) ERK signaling |
| Alh | CG1070 | 1) Cell growth and viability 2) Mito Ca2+ and H+ regulation 3) Notch signaling |
| CG6028 | CG6028 | Not detected |
| tna | CG7958 | 1) Cell growth and viability 2) Wnt signaling 3) Notch signaling 4) Hedgehog signaling 5) Ca2+ signaling 6) Dpp signaling 7) Interferon-gamma signaling pathway 8) JAK/STAT signaling pathway |
| CG14185 | CG14185 | Notch signaling |
| Manf | CG7013 | Not detected |
| ci | CG2125 | 1) Hedgehog signaling 2) Notch signaling |
Signaling pathways are based on DAVID (KECK and PANTHER database) and FLIGHT database.
Figure 3Gene expression in P-element lines. Real-time PCR analysis of P-element lines in normoxia and hypoxia. Means are statistically significant when P < 0.05 (unpaired t-test comparing P-element lines with yw control).
Figure 4Effect of alterations of single genes on hypoxia tolerance phenotype. Percentage eclosion of flies in which single genes were overexpressed or knocked out based on the real time PCR analysis of P-element lines. Each bar represents the average of at least three tests for each line (starting with 100–150 eggs); error bars represent the standard error.
Figure 5Effect of tissue-specific overexpression of osa. Osa was upregulated in specific tissues using Gal4 drivers: (elav-gal4) nervous system, (c736) mushroom body of the brain, and (P{GawB}DJ667) muscle driver. The figure shows percentage eclosion of F1 progeny of the crosses. Each bar represents the average of at least three tests for each line (starting with 100–150 eggs); error bars represent the standard error.
Figure 6Effect of tissue-specific overexpression of lqf. lqf was upregulated in specific tissues using Gal4 drivers: (Eaat1) glial cells, (Hml-Gal4) larval hemocytes, and (P{GawB}DJ667) muscle driver. The figure shows percentage eclosion of F1 progeny of the crosses. Each bar represents the average of at least three tests for each line (starting with 100–150 eggs); error bars represent the standard error.